SlidesetHIVViral Hepatitis and Liver DiseaseCentral and Eastern European Meeting on Viral Hepatitis and HIV 2020ART in Women: Which Drugs are Safe and What are the Challenges? - Dr. Annette HaberlView Slideset
SlidesetHIVViral Hepatitis and Liver DiseaseCentral and Eastern European Meeting on Viral Hepatitis and HIV 2020The Acute HCV Epidemic in MSM: What Have We Learned Thus Far? Christoph BoeseckeView Slideset
SlidesetHIVViral Hepatitis and Liver DiseaseCentral and Eastern European Meeting on Viral Hepatitis and HIV 2020Managing Highly Treatment-Experienced Patients - Prof. Anca Streinu Cercel -View Slideset
VideoHIVViral Hepatitis and Liver DiseaseCentral and Eastern European Meeting on Viral Hepatitis and HIV 2020The Acute HCV Epidemic in MSM: What Have We Learned Thus Far? - Christoph BoeseckeView Video
VideoHIVViral Hepatitis and Liver DiseaseCentral and Eastern European Meeting on Viral Hepatitis and HIV 2020Managing Highly Treatment-Experienced Patients: What are the New Drug Options - Prof. Anca Streinu CercelView Video
VideoHIVViral Hepatitis and Liver DiseaseCentral and Eastern European Meeting on Viral Hepatitis and HIV 2020Management of Viral Hepatitis During Pregnancy - Dr. Yvonne GilleeceView Video
VideoHIVViral Hepatitis and Liver DiseaseCentral and Eastern European Meeting on Viral Hepatitis and HIV 2020ART in Women: Which Drugs are Safe and What are the Challenges? - Dr. Annette HaberlView Video
VideoHIVViral Hepatitis and Liver DiseaseCentral and Eastern European Meeting on Viral Hepatitis and HIV 2020PrEP Implementation in the CEE Region - Prof. Milosz ParczewskiView Video
VideoHIVViral Hepatitis and Liver DiseaseCentral and Eastern European Meeting on Viral Hepatitis and HIV 20202020: Have We Reached the 90-90-90 Targets? - Teymur NooriView Video
SlidesetHIVRSVLiverpool Course 2020Clinical Case: Switching Patients - Including for DDIs - Dr. Pavel KhaykinView Slideset
SlidesetRSVCOVID-19Liverpool Course 2020COVID-19, Me and Clinical Pharmacology - Dr. Andrea CalcagnoView Slideset
